The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC study.
 
Eiji Kashiwagi
No Relationships to Disclose
 
Yoshiki Asayama
Other Relationship - Canon Medical System
 
Takashi Hatano
No Relationships to Disclose
 
Jun Miki
No Relationships to Disclose
 
Shin Egawa
Research Funding - Kissei Pharmaceutical; Ono Pharmaceutical; Takeda
 
Atsushi Takamoto
No Relationships to Disclose
 
Yasutomo Nasu
No Relationships to Disclose
 
Takahiro Osawa
No Relationships to Disclose
 
Nobuo Shinohara
Honoraria - Astellas Pharma; AstraZeneca; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst)
 
Fumiya Hongo
No Relationships to Disclose
 
Osamu Ukimura
Consulting or Advisory Role - EDAP TMS
Research Funding - Boston scientific (Inst)
Patents, Royalties, Other Intellectual Property - Kyosera Commnunications
 
Akihiro Nishie
No Relationships to Disclose
 
Yasuhiro Ushijima
No Relationships to Disclose
 
Fumiaki Kiyomi
No Relationships to Disclose
 
Shuji Nakano
No Relationships to Disclose
 
Yasuaki Arai
Honoraria - Canon Medical System; Chugai Pharma; Cosmotec; Daiichi Sankyo; Merit Medical Systems; Merit Medical Systems; Nippon Covidien; Takeda
Consulting or Advisory Role - Boston Scientific
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Johnson & Johnson; Merck; Ono Pharmaceutical; Pfizer; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology; Merck; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)